I am thrilled about the current research investigating the potential use of weight-loss medications, such as Ozempic and Wegovy, for treating Binge Eating Disorder (BED). A recent article in the New York Times references one of the limited studies conducted in this field, indicating that further investigation is warranted. More treatment options are needed for those struggling with BED, and I am by no means endorsing these medications as a quick fix. However, I believe that with more research, we could uncover new ways to prescribe these medications at different doses tailored specifically for individuals with BED. This represents a promising development in the search for additional effective treatment options.